
ZebraMed is building the world's first data engine to generate systemic, in vivo data at an industrial scale, making AI-driven drug discovery finally predictive. Their platform addresses the 'Systemic Data Gap' in pharma by industrializing in vivo data generation through a hybrid hardware/robotics platform, utilizing the zebrafish model at scale, and powered by their AI engine ZebrAI™. This approach aims to bridge the translational gap between AI predictions and human clinical outcomes, offering over 80% translatability. They have secured Letters of Intent from AI-Biotech & Pharma leaders and are generating significant commercial interest.

ZebraMed is building the world's first data engine to generate systemic, in vivo data at an industrial scale, making AI-driven drug discovery finally predictive. Their platform addresses the 'Systemic Data Gap' in pharma by industrializing in vivo data generation through a hybrid hardware/robotics platform, utilizing the zebrafish model at scale, and powered by their AI engine ZebrAI™. This approach aims to bridge the translational gap between AI predictions and human clinical outcomes, offering over 80% translatability. They have secured Letters of Intent from AI-Biotech & Pharma leaders and are generating significant commercial interest.